Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kevin R Kipp"'
Autor:
Nicholas Doerr, Yidi Wang, Kevin R Kipp, Guangyi Liu, Jesse J Benza, Vladimir Pletnev, Tengis S Pavlov, Alexander Staruschenko, Ashraf M Mohieldin, Maki Takahashi, Surya M Nauli, Thomas Weimbs
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161525 (2016)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that leads to progressive renal cyst growth and loss of renal function, and is caused by mutations in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), respe
Externí odkaz:
https://doaj.org/article/2dd1bd64898141e3a8683112f025fee9
Autor:
Luke J Nelson, Kyleen E Castro, Binzhi Xu, Junyi Li, Nguyen B Dinh, Jordan M Thompson, Jordan Woytash, Kevin R Kipp, Olga V Razorenova
Publikováno v:
Cell cycle (Georgetown, Tex.), vol 21, iss 10
Clear cell renal cell carcinoma (CC-RCC) remains one of the most deadly forms of kidney cancer despite recent advancements in targeted therapeutics, including tyrosine kinase and immune checkpoint inhibitors. Unfortunately, these therapies have not b
Autor:
Masaw Akbari, Jonathan D. West, Nicholas Doerr, Kevin R. Kipp, Neda Marhamati, Sabrina Vuong, Yidi Wang, Markus M. Rinschen, Jeffrey J. Talbot, Oliver Wessely, Thomas Weimbs
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, vol 119, iss 30
Akbari, M, West, J D, Doerr, N, Kipp, K R, Marhamati, N, Vuong, S, Wang, Y, Rinschen, M M, Talbot, J J, Wessely, O & Weimbs, T 2022, ' Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression ', Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 30, e2121267119 . https://doi.org/10.1073/pnas.2121267119
Akbari, M, West, J D, Doerr, N, Kipp, K R, Marhamati, N, Vuong, S, Wang, Y, Rinschen, M M, Talbot, J J, Wessely, O & Weimbs, T 2022, ' Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression ', Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 30, e2121267119 . https://doi.org/10.1073/pnas.2121267119
Autosomal dominant polycystic kidney disease (ADPKD) affects more than 500,000 individuals in the United States alone. In most cases, ADPKD is caused by a loss-of-function mutation in the PKD1 gene, which encodes polycystin-1 (PC1). Previous studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f72725d05c6f86d382499b53f3482e3
https://escholarship.org/uc/item/0rw4q0ck
https://escholarship.org/uc/item/0rw4q0ck
Autor:
Samantha L Kruger, Nikki Parker, Thomas Weimbs, Margaret F Schimmel, Kevin R. Kipp, Christopher P. Leamon, Jonathan M. Shillingford
Publikováno v:
American Journal of Physiology-Renal Physiology. 315:F395-F405
Autosomal-dominant polycystic kidney disease (ADPKD) is a very common genetic disease leading to renal failure. Numerous aberrantly regulated signaling pathways have been identified as promising molecular drug targets for ADPKD therapy. In rodent mod
Autor:
Nick Doerr, Laith Q. Al-Mawsawi, Adrian J. Giovannone, Nazli Azimi, Kevin R. Kipp, Woo Jae Kim
Publikováno v:
Cancer Research. 81:LB143-LB143
Advances in adoptive transfer immunotherapy have found beneficial effects for Interleukin-15 (IL-15) in the graft versus tumor (GvT) activity of NK and cytotoxic T cells. However, the benefits of this activity must be weighed against the increased ri
Publikováno v:
American Journal of Physiology-Renal Physiology. 310:F726-F731
Autosomal-dominant polycystic kidney disease (ADPKD) is a common cause of end-stage renal disease, and no approved treatment is available in the United States to slow disease progression. The mammalian target of rapamycin (mTOR) signaling pathway is
Autor:
Guangyi Liu, Maki Takahashi, Jesse J. Benza, Ashraf M. Mohieldin, Surya M. Nauli, Kevin R. Kipp, Tengis S. Pavlov, Nicholas Doerr, Thomas Weimbs, Vladimir Z. Pletnev, Yidi Wang, Alexander Staruschenko
Publikováno v:
PloS one, vol 11, iss 8
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0161525 (2016)
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0161525 (2016)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that leads to progressive renal cyst growth and loss of renal function, and is caused by mutations in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), respe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3ba13798c5599980be5f04b0d3c0de
https://escholarship.org/uc/item/7pn0w1cg
https://escholarship.org/uc/item/7pn0w1cg
Publikováno v:
The Prostate. 74:1576-1578
Publikováno v:
The Prostate. 69:1493-1506
BACKGROUND Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are lipid mediators that bind to G-protein-coupled receptors. In this study, signaling responses to 18:1 LPA and S1P were examined in parallel in three human prostate cancer cel
Autor:
Roberta M. Kato, Wilfried Ellmeier, Kevin R. Kipp, Phyllis W. Yu, Stephanie Humblet-Baron, Alexander Astrakhan, Owen N. Witte, Ruby S. Tabuchi, David J. Rawlings, Keun Chae
Publikováno v:
Blood. 104:1281-1290
X-linked agammaglobulinemia (XLA) is a human immunodeficiency caused by mutations in Bruton tyrosine kinase (Btk) and characterized by an arrest in early B-cell development, near absence of serum immunoglobulin, and recurrent bacterial infections. Us